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The change in hematocrit (ΔHct) following packed red blood cell (pRBCs) transfusion is a clinically relevant measurement of
transfusion eﬃcacy that is inﬂuenced by post-transfusion hemolysis. Sexual dimorphism has been observed in critical illness
a n dm a yb er e l a t e dt og e n d e r - s p e c i ﬁ cd i ﬀerences in immune response. We investigated the relationship between both donor and
recipientgenderandΔHctinananalysisofallpRBCstransfusionsinoursurgicalintensivecareunit(2006–2009).Therelationship
between both donor and recipient gender and ΔHct (% points) was assessed using both univariate and multivariable analysis. A
totalof575unitsofpRBCsweregivento342patients;289(49.9%)donorsweremale.Byunivariateanalysis,ΔHctwassigniﬁcantly
greater for female as compared to male recipients (3.81% versus 2.82%, resp., P<0.01). No association was observed between
donor gender and ΔHct, which was 3.02% following receipt of female blood versus 3.23% following receipt of male blood (P =
0.21). By multivariable analysis, recipient gender remained associated signiﬁcantly with ΔHct (P<0.01). In conclusion, recipient
gender is independently associated with ΔHct following pRBCs transfusion. This association does not appear related to either
demographic or anthropomorphic factors, raising the possibility of gender-related diﬀerences in recipient immune response to
transfusion.
1.Introduction
Transfusion of critically ill patients with packed red blood
cells (pRBCs) is commonplace; nearly all anemic intensive
care unit (ICU) patients with a length of stay (LOS) ≥ 7
days receive at least one pRBCs transfusion [1, 2]. Despite
the widespread use of pRBCs transfusions as a treatment
of ICU anemia, there are a paucity of data demonstrating
their eﬃcacy in terms of improvement of oxygen delivery,
oxygen consumption, and ultimately patient outcome [3–
6]. By contrast, research over the last several decades has
elucidated the detrimental eﬀects of blood product transfu-
sion, particularly with respect to immune suppression, in-
fection, inﬂammation, and organ failure [5, 7–9]. Such
phenomenaarebelievedtoinvolvebothtransfusionandhost
response components. In the case of the former, proinﬂam-
matory components within the transfusion, such as leuko-
cytes,cytokines,andantibodies, inﬂictdamagedirectlyupon
recipient organ systems (including the immune system). In
the case of the later, the recipient immune system reacts
to antigens within the transfused blood, such as proin-
ﬂammatory cytokines, lipid mediators, and the erythrocytes
themselves, which may in turn cause collateral damage to the
host [10, 11].
Research on the impact of gender on ICU outcomes has
received recent attention and yielded conﬂicting results.
Several studies have reported sexual dimorphism with re-
spect to both overall and infection-related mortality among
critically ill patient cohorts ranging from severe trauma
[12, 13]t op o s t c a r d i a ca r r e s t[ 14]. Demonstration of sexual2 ISRN Hematology
dimorphisminbothriskandsurvivalofseveresepsis[15,16]
has led investigators to invoke gender-related diﬀerences
in immune response as a potential etiology. Speciﬁcally,
laboratory investigations have demonstrated an immuno-
suppressive eﬀect of androgens [17–19], and gender-related
genetic polymorphisms have been observed with respect to
human proinﬂammatory proteins [20].
Evidence of a possible immune-related sexual dimor-
phism with respect to outcomes following blood product
transfusion has been reported by our group and others.
Speciﬁcally, transfusion-related acute lung injury appears
both more frequent and severe following transfusion of
female blood as compared to male blood [21, 22]. Further-
more, we observed both decreased survival and more aggres-
sive tumor behavior for male mice, as compared to female
mice, inoculated with pancreatic cancer cells following
transfusion of female blood [23, 24]. Such diﬀerences may
involve alloimmunization [22, 25] or even microchimerism
[26] of multiparous female donors.
We have investigated the change in hematocrit (ΔHct)
following pRBCs transfusion as a clinically relevant potential
surrogate marker of posttransfusion hemolysis. Speciﬁcally,
based upon the associations between pRBCs storage time,
accumulation of inﬂammatory mediators [27–29], and
decreased erythrocyte longevity [30], we demonstrated a sig-
niﬁcantinverserelationshipbetweenpRBCsstoragetimeand
ΔHctfollowingtransfusion[31].Theobjectiveofthecurrent
investigationwastodeterminetherelationshipbetweenboth
donor and recipient gender and ΔHct following pRBCs
transfusion of critically ill surgical patients. Based upon
the aforementioned observations, we hypothesized that both
female donor gender and female recipient gender would be
associated with a decreased ΔHct.
2.MaterialandMethods
This study was a cross-sectional analysis of all leukocyte-
reduced, pRBCs transfusions administered to critically ill
patients from June 2006 through June 2009 at a 20-
bed academic surgical ICU. Only single-unit transfusions
that occurred while the patient was in the ICU were
included; multiple unit transfusions as well as transfusions
administered at other locations (e.g., operating room and
angiography suite) were excluded.
The independent variables of interest were both donor
and recipient gender. For the purposes of this analysis,
gender refers to sex chromosomal status: XX for female and
XY for male. The outcome variable was the ΔHct following
pRBCs transfusion (% points, continuous). ΔHct was cal-
culated as the diﬀerence between the ﬁrst posttransfusion
value (Hctpost) and the last pretransfusion value (Hctpre).
ThetimefromHctpre determinationtothebloodtransfusion
(Tpre, hours), as well as the time from the blood transfusion
to Hctpost determination (Tpost, hours) were also abstracted.
I no r d e rt oa c c e s sf o rap o t e n t i a le ﬀect of ﬂuid equilibra-
tion over time, we also abstracted the second hematocrit
determination following pRBCs transfusion (Hctpost2,%
points, continuous). This data point was used to calculate
ΔHct2 (% points, continuous), deﬁned as the diﬀerence
between Hctpost2 and Hctpre. Transfusion of additional blood
products(e.g.,freshfrozenplasma,platelets,andcryoprecip-
itate) along with the pRBCs transfusion was also recorded.
The following covariates were hypothesized ap r i o r ito
potentially confound the relationship between gender and
ΔHct: recipient age (years), recipient admission diagnosis
(trauma versus other), the indication for transfusion (hem-
orrhage versus ICU anemia, the former being identiﬁed by
the terms “bleeding” or “hemorrhage” used in the med-
ical record within 48 hours of the transfusion), recipient
admission weight (kg), recipient admission body mass index
(BMI, kg/m2), recipient 24 hour ﬂuid balance (L), time from
surgical ICU admission to transfusion (days), Hctpre (%),
and the age of transfused blood. Recipient ICU LOS (days)
as well as mortality was also abstracted.
All statistical analyses were performed using SAS version
9.2 (SAS Inc., Carey, NC, USA). The alpha error level was
set at 0.05, with P<0.05 being considered signiﬁcant
statistically, unless indicated otherwise. Continuous data are
expressed as mean, range; categorical data are expressed as
number, %. Correlations between predictor variables and
ΔHct were assessed using Pearson’s correlation coeﬃcient
(r2). The means of two continuous variables were compared
using the student’s t-test. The means of >2g r o u p sw e r e
compared using ANOVA (F statistic); individual group
diﬀerences were then compared using Tukey’s test in the case
of overall signiﬁcance. It the case of multiple comparisons
Bonferroni-corrected P-values were used and calculated as
0.05/k,w h e r ek is equal to the number of groups analyzed.
Diﬀerences in proportions of categorical variables were
compared using the chi-square test, except when expected
cell counts were <10, in which case Fischer’s exact test was
used. Multivariable linear regression (sum of squares) was
used to access for the independent contribution of gender
to the variability in ΔHct. Variables correlated with either
recipient gender or ΔHct (or both) at the P ≤ 0.10 level
by univariate analysis were entered into the model using a
forward selection method. Overall model signiﬁcance was
calculated using the F statistic, with the signiﬁcance of
individualvariablescalculatedusingthet statistic.Thisstudy
was approved by the Colorado Multiple Institutional Review
Board (Protocol no.10-0028).
3. Results
A total of 1,011 units of pRBCs were administered during
the study period. Of these, 594 (56.9%) units were given
to 342 patients as single-unit transfusions. Complete data
were available for 575 (96.8%) units, which served as the
ﬁnalsamplesize.SampledemographicsareshowninTable 1.
The vast majority of pRBCs transfusions were given for ICU
anemia (91.4%), well into the recipient’s ICU course (mean
time from ICU admission to transfusion 13.7 days), and
withoutadditionalbloodproducts(95.1%).ThemeanHctpre
was 21.5 (range 8.2–32). The mean pRBCs storage time was
29.5 days, and 94.3% of pRBCs units were ≥14 days old.
Donor gender was distributed equally among male (49.9%)
and female (50.1%) donors.ISRN Hematology 3
Table 1: Sample demographics.
Variable (n = 575) Mean/N Range/%
Recipient characteristics
Age (years) 49.3 18–93
Male gender 398 68.7%
Admission diagnosis of trauma 384 66.3%
Transfusion indication of ICU anemia 529 91.4%
Admission weight (kg) 82.2 40.8–185.0
Admission BMI (kg/m2) 27.9 16.8–66.3
24 Hour ﬂuid balance (L) 2.1 −5.6–55.9
Transfusion data
Time from ICU admission to 13.7 1–71
transfusion (days)
Hctpre (% points)
21.5 10.2–32
Tpre (hours) 3.3 1–7
Tpost (hours) 4.6 1–6
pRBCs storage time (days) 29.5 7–42
Donor male gender 289 49.9%
Additional blood products 28 4.9%
Outcomes
ΔH c t( %p o i n t s ) 3.1 −7.0–16.9
ICU LOS (days) 27.4 1–111
Recipient mortality 119 20.7%
ICU, intensive care unit; BMI, body mass index; pRBCs, packed red blood
cells; LOS, length of stay.
Correlations between independent variables and ΔHct
are listed in Table 2. Recipient female gender (r2 = 0.23,
P<0.01) and Hctpre (r2 =− 0.27, P<0.01) were correlated
most strongly with ΔHct. Additional signiﬁcant correlations
[in order of decreasing magnitude (|r2|)] were as follows:
increasing recipient admission weight was associated with a
decreased ΔHct (r2 =− 0.15, P<0.001), transfusion for
ICU anemia as opposed to hemorrhage was associated with
a decreased ΔHct (r2 = 0.13, P = 0.003), increasing age
was associated with an increased ΔHct (r2 = 0.10, P =
0.02), increasing 24 hour ﬂuid balance was associated with
a decreased ΔHct (r2 = 0.10, P = 0.02), and increasing Tpre
was associated with increased ΔHct (r2 = 0.09, P<0.04).
Admission diagnosis, recipient admission BMI, time from
ICU admission to transfusion, Tpost, the age of blood, donor
gender, and transfusion of additional blood products with
the pRBCs unit were not correlated signiﬁcantly with ΔHct.
Table 3 lists sample characteristics stratiﬁed by recipient
gender. As compared to female recipients, male recipients
were signiﬁcantly younger (P<0.0 1 ) ,m o r el i k e l yt oh a v ea n
admission diagnosis of trauma (P<0.01), more likely to be
transfused for an indication of ICU anemia (P<0.01), had a
higher BMI (P<0.01), and received older blood (P<0.01).
By univariate analysis, ΔHct was signiﬁcantly greater for
female recipients, as compared to male recipients (3.81%
versus 2.82%, resp., P<0.01). However, donor gender did
not impact ΔHct, which was 3.02% following receipt of
female blood versus 3.23% following receipt of male blood
Table 2: Univariate correlations with ΔHct.
Variable r2 P
Recipient characteristics
Age (years) 0.10 0.02
Male gender −0.23 <0.01
Admission diagnosis of trauma −0.01 0.74
Transfusion indication of ICU anemia 0.13 <0.01
Admission weight (kg) −0.15 <0.01
Admission BMI (kg/m2) −0.02 0.63
24 Hour ﬂuid balance (L) −0.10 0.02
Transfusion data
Time from ICU admission to
transfusion (days)
−0.04 0.35
Hctpre (% points) −0.27 <0.01
Tpre (hours) 0.09 0.04
Tpost (hours) 0.05 0.27
pRBCs storage time (days) −0.01 0.68
Donor male gender 0.05 0.21
Additional blood products −0.06 0.13
r2,P e a r s o n ’ sc o r r e l a t i o nc o e ﬃcient; ICU, intensive care unit; BMI, body
mass index; pRBCs, packed red blood cells.
(P = 0.21). In order to assess for any possible eﬀect of
ﬂuid equilibration over time, these analyses were repeated
using ΔHct2 instead of ΔHct. The mean ΔHct2 was 2.97%
(range −12.3, 15.8) and the mean Tpost2 was 14.1 hours
(range1–92). ΔHct2 remainedsigniﬁcantlyhigherforfemale
as compared to male recipients (3.71% versus 2.63%, resp.,
P<0.01). Furthermore, donor gender was not associated
with ΔHct2 (2.91% following receipt of female blood versus
3.03% following receipt of male blood, P = 0.55).
The relationship between both donor and recipient gen-
der and ΔHct was explored further by stratifying the sample
intothe4donor-recipientgenderpairslistedinTable 4:M ale
donor male recipient (MM), female donor male recipient
(FM), male donor female recipient (MF), and female donor
female recipient (FF). ΔHct for each of these pairs is listed
in Table 4 and depicted in Figure 1. Although signiﬁcant
diﬀerences in ΔHct existed between these 4 groups (ANOVA
DF = 3, F = 10.78, P<0.01), analysis of diﬀerences
between individual pairs revealed only those with disparate
recipient genders to be signiﬁcant. By contrast, ΔHct was not
signiﬁcantly diﬀerent when comparing pairs with disparate
donor genders and identical recipient genders. Diﬀerences
in ΔH c ta sw e l la sa d j u s t e dP-values for individual pair
comparisons are listed in Figure 1.
Results from multivariable logistic regression analysis are
shown in Table 5. The following variables were added to
the model in addition to recipient gender based on their
association with either recipient gender or ΔHct (or both) by
univariate analysis: recipient age, admission diagnosis, indi-
cation for transfusion, Hctpre, recipient admission weight,
Tpre, age of blood, and recipient 24 hour ﬂuid balance. Of
note, recipient BMI was not included in the model based on
a high degree of colinearity with recipient weight (r 2 = 0.90,4 ISRN Hematology
Table 3: Sample characteristics stratiﬁed by recipient gender.
Variable Male Recipient (n = 398) Female recipient (n = 177) P
Recipient characteristics
Age (years) 48.0 52.5 <0.01
Admission diagnosis of trauma 296 (74.8%) 87 (48.6%) <0.01
Transfusion indication of ICU anemia 351 (88.6%) 172 (97.2%) <0.01
Admission weight (kg) 82.7 81.2 0.44
Admission BMI (kg/m2) 30.9 26.6 <0.01
24 Hour ﬂuid balance (L) 2.0 2.1 0.73
Transfusion data
Time from ICU admission to transfusion (days) 14.1 12.8 0.22
Hctpre (% points) 21.6 21.3 0.13
Tpre (hours) 3.2 3.3 0.73
Tpost (hours) 4.5 4.7 0.69
pRBCs storage time (days) 30.4 27.7 <0.01
Donor male gender 197 (49.8%) 92 (51.4%) 0.71
Additional blood products 16 (4.0%) 12 (6.7%) 0.17
ICU, intensive care unit; BMI, body mass index; pRBCs, packed red blood cells.
Table 4: Change in hematocrit following transfusion stratiﬁed by
donor-recipient gender pairs.
Donor Recipient N ΔHct
Male Female Male Female
•• 197 (34.0%) 2.94
•• 201 (34.7%) 2.48
•• 92 (15.9%) 3.85
•• 89 (15.4%) 3.76
P<0.01). After controlling for these covariates, recipient
genderremainedsigniﬁcantlyassociatedwithΔHct(t =4.32,
P<0.01) (model DF-9, F-12.57, P<0.01). In additional
to recipient gender, patient age, Hctpre, recipient admission
weight, and Tpre were also associated independently with
ΔHct.
4. Discussion
Inthiscross-sectionalanalysisofanemic,criticallyillsurgical
patients, we observed an independent association between
recipient gender and ΔHct following pRBCs transfusion. By
contrast, a relationship between donor gender and ΔHct was
not observed. Speciﬁcally, ΔHct was higher for female, as
compared to male recipients, irrespective of donor gender.
Demonstration of sexual dimorphism with respect to
recipient gender in this retrospective analysis raises the issues
of both confounding and causality. In terms of the former,
several covariates may confound the relationship between
recipient gender and ΔHct. Chronologic factors, such as Tpre
and Tpost, would appear to inﬂuence ΔHct but were not
associated strongly with either recipient gender or ΔHct in
this analysis, nor did they signiﬁcantly alter the observed
relationship between these two variables in multivariable
analysis. Furthermore, because pRBCs transfusion in eﬀect
entails adding a relatively ﬁxed volume and concentration
of erythrocytes to a variable recipient volume of distribution
and Hct, variables such as Hctpre, recipient weight, 24 hour
ﬂuid balance, and recipient BMI are of relevance. Indeed,
each of these variables was correlated with ΔHct but did
not explain the association between recipient gender and
ΔHct. Finally, male and female recipients may have diﬀered
with respect to the condition of the donor erythrocytes
themselves. Speciﬁcally, we recently observed that older
blood is less eﬀective in raising the Hct [31]. This possibility
wasaddressedbyabstractingtheageofthetransfusedpRBCs
unit. However, although females tended to receive newer
blood than males (27.7 days versus 30.4 days, P<0.01),
this relatively small degree of diﬀerence in storage time was
not found to signiﬁcantly alter ΔHct in our previous work
[31]. Furthermore, adding the age of blood to the regression
model in this analysis did not eliminate the observed
association between recipient gender and ΔHct. Thus, to
the best of our ability to control for such confounding
variables, female recipients were noted to raise their Hct by a
greateramountthantheirmalecounterpartsbyamechanism
independent of either chronologic or dilutional phenomena.
The immunomodulatory properties of pRBCs transfu-
sions involve both donor and recipient qualities. Previous
work has implicated transfusion of female blood in both
antibody-mediated acute lung injury [22] and cancer pro-
gression [23, 24] and invoked alloimmunization of multi-
parous women as one possible etiology. Similarly, androgens
have been shown to possess immunosuppressive properties
[19].Inthisstudy,however,wedidnotobservearelationship
between donor gender and ΔHct. This ﬁnding suggests
that any gender-related diﬀerence in passenger immunologic
components (e.g., pro-inﬂammatory cytokines, antibod-
ies) did not appreciably result in hemolysis of recipient
(or transfused) erythrocytes as reﬂected by the ﬁrst two
posttransfusion hematocrits. By contrast, recipient gender
appeared to drive the sexual dimorphism in ΔHct, withISRN Hematology 5
Table 5: Multivariable linear regression.
Variable Parameter estimate Standard error P
Recipient age (years) 0.016 0.005 <0.01
Admission diagnosis of trauma 0.240 0.182 0.19
Transfusion indication of ICU Anemia 0.434 0.290 0.13
Hctpre (% points) −0.269 0.036 <0.01
Recipient admission weight (kg) −0.013 0.004 <0.01
Tpre (hours) 0.073 0.027 <0.01
pRBCs storage time (days) 0.001 0.009 0.95
24 Hour ﬂuid balance (L) −0.001 0.001 0.08
Recipient female gender 0.793 0.183 <0.01
ICU, intensive care unit; pRBCs, packed red blood cells; model DF = 9, F = 12.57, P<0.01.
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Figure 1: Change in Hematocrit as a function of donor-recipient
gender pair. Donor-recipient pairs: FM, female donor male recip-
ient; MM, male donor male recipient; FF, female donor female
recipient; MF male donor female recipient. Pair 1 − Pair 2 = ΔHct
for pair 1 −ΔHct for pair 2. P∗, Bonferroni-corrected P value =
0.05/4 groups = 0.0125. All comparisons in which the recipient
genders were discordant were signiﬁcant statistically. By contrast,
comparisons in which the recipient genders were identical were not
signiﬁcant statistically.
female recipients demonstrating a signiﬁcantly greater ΔHct
as compared to male recipients.
We hypothesized originally a smaller ΔHct for female, as
comparedtomalerecipientsbaseduponpossibleimmuneor
sex hormone-mediated posttransfusion hemolysis. However,
the opposite eﬀect was observed. One possible explana-
tion for this ﬁnding involves immunologic tolerance via
microchimerism. Microchimerism entails proliferation of
a relatively small (<5%) population of cells (e.g., leuko-
cytes) from a distinct zygote and as a result of mixing
of blood between the two organisms. Examples of cir-
cumstances leading to microchimerism include solid organ
transplantation, pregnancy, and blood transfusion itself.
One hypothesis for the observed ﬁndings thus involves a
lesser degree of immune-mediated hemolysis of transfused
pRBCs in female, as compared to male recipients, as a result
of microchimerism-mediated immune tolerance. Although
testing of this hypothesis is beyond the scope of our
dataset, microchimerism and its relationship to immune
tolerance represent an important development in the ﬁeld of
transfusionthatmayhelptoelucidatethesexualdimorphism
observed in various outcomes of critically ill patients. Be-
yond microchimerism, immunologically relevant gender
diﬀerences in sex hormone expression may contribute to the
observed sexual dimorphism in ΔHct. Continued research
is necessary to elucidate and potentially manipulate the
observed gender-related disparity in the hopes of ultimately
decreasing both patient exposure to and morbidity of alloge-
neic blood product transfusion.
Out study is limited by a retrospective design. We were
unable to capture additional variables that may have inﬂu-
enced ΔHct irrespective of recipient gender such as donor
and recipient sex hormone concentrations, menopausal
status, and obstetric and transfusion histories. Markers of
hemolysis, such as haptoglobin, bilirubin, lactate dehydro-
genase, and iron, as well as the presence of hemoglobin-
uria, were not measured routinely. Demonstration of an
association between these markers and ΔHct would provide
furtherevidenceforthehemolysishypothesisandisthefocus
of a current prospective study in our surgical ICU. Study
strengths include a large and relatively uniform sample of
critically ill surgical patients, rigorous collection of chrono-
logic and demographic variables, and a low percentage of
missing data.
5. Conclusions
Among this cohort of critically ill surgical patients, we
observed a signiﬁcant association between recipient gender
and ΔHct following pRBCs transfusion, such that female
recipients raised their hematocrit more than male recipients.6 ISRN Hematology
This relationship was independent of either chronologic or
anthropomorphicfactors,diﬀerencesintheageoftransfused
blood, and the gender of the donor. No relationship was
observed between donor gender and ΔHct in any analysis.
Additional factors that were associated independently with
ΔHct included recipient age, recipient admission weight,
Hctpre,a n dT pre. The etiology of the observed sexual
dimorphism is unknown but may involve gender-related
diﬀerences in immune-mediated hemolysis of transfused
erythrocytes; additional research at our institution is focused
on exploring this hypothesis.
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